Literature DB >> 6842678

Role of antibodies and host cells in plaque enhancement of Murray Valley encephalitis virus.

S C Kliks, S B Halstead.   

Abstract

Chicken antisera to Murray Valley encephalitis (MVE) virus, when incubated with virus and assayed for plaques on chicken embryo (CE) monolayers, neutralized MVE virus at high concentrations of antibody, but caused increases in plaque counts at low concentrations of antibody. Plaque enhancement did not occur when the same virus-antibody mixtures were assayed on a continuous line of rhesus monkey kidney cells (LLC-MK2), nor when the anti-MVE antibody was of mammalian origin and the assay system was CE monolayers. Correspondingly, chicken anti-MVE did not enhance the plaque formation of MVE virus in a stable line of mouse macrophages, P-388D1, whereas rabbit and mouse anti-MVE did enhance plaque formation. This enhancing activity was associated with noncytophilic immunoglobulin G (IgG). The Fc terminus of the IgG molecule was required, as no plaque enhancement occurred with chicken anti-MVE Fab. These data indicate that there is a requirement for taxonomic complementarity between Fc termini and Fc receptors in the above systems. CE cell monolayers were found to contain approximately 2% of Fc receptor-bearing cells among the fibroblast-like cells. Fc receptor-bearing cells in CE monolayers were isolated and found to be of the mononuclear phagocytic lineage. These mononuclear phagocytes, which originate in lymphoid tissues and blood associated with CE tissue fragments, are integrated into primary CE monolayers and form infectious centers in the presence of virus and low dilutions of antibody.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842678      PMCID: PMC255141     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  EA rosette forming lymphoid cells: distribution as to cell types and organs from chickens of different developmental stages.

Authors:  S Ewald; L Freedman; B G Sanders
Journal:  Cell Immunol       Date:  1976-04       Impact factor: 4.868

2.  ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS.

Authors:  R A HAWKES
Journal:  Aust J Exp Biol Med Sci       Date:  1964-08

3.  The development of bactericidal activity in rat peritoneal macrophages.

Authors:  P C Reade
Journal:  Aust J Exp Biol Med Sci       Date:  1968-04

4.  Studies on the non-neutralizable fraction of vaccinia virus.

Authors:  M Majer; F Link
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

5.  Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse.

Authors:  A C Sartorelli; D S Fischer; W G Downs
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

6.  Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host.

Authors:  S B Halstead; P Simasthien
Journal:  Yale J Biol Med       Date:  1970-04

7.  Growth characteristics of monkey kidney cell strains LLC-MK1, LLC-MK2, and LLC-MK2(NCTC-3196) and their utility in virus research.

Authors:  R N HULL; W R CHERRY; O J TRITCH
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

8.  Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses.

Authors:  S B Halstead; S Udomsakdi; P Simasthien; P Singharaj; P Sukhavachana; A Nisalak
Journal:  Yale J Biol Med       Date:  1970-04

9.  Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin.

Authors:  H B Dickler
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

10.  Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection.

Authors:  S B Halstead; E J O'Rourke; A C Allison
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  5 in total

Review 1.  How innate immune mechanisms contribute to antibody-enhanced viral infections.

Authors:  Sukathida Ubol; Scott B Halstead
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

Review 2.  Macrophages and control of granulomatous inflammation in tuberculosis.

Authors:  J L Flynn; J Chan; P L Lin
Journal:  Mucosal Immunol       Date:  2011-03-23       Impact factor: 7.313

Review 3.  Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.

Authors:  Scott B Halstead; Suresh Mahalingam; Mary A Marovich; Sukathida Ubol; David M Mosser
Journal:  Lancet Infect Dis       Date:  2010-10       Impact factor: 25.071

Review 4.  Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.

Authors:  Rekha Khandia; Ashok Munjal; Kuldeep Dhama; Kumaragurubaran Karthik; Ruchi Tiwari; Yashpal Singh Malik; Raj Kumar Singh; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

5.  Neglected Australian Arboviruses Associated With Undifferentiated Febrile Illnesses.

Authors:  Narayan Gyawali; Andrew W Taylor-Robinson; Richard S Bradbury; Wayne Pederick; Helen M Faddy; John G Aaskov
Journal:  Front Microbiol       Date:  2019-12-06       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.